This drug card summarizes information about Albuterol (AccuNeb, Proventil, VoSpire) for pediatric patients. It provides the drug classification, recommended dosages based on weight (ranging from 0.63mg to 2.5mg), administration route of inhalation via nebulizer, and frequency of every 5 to 15 minutes as needed up to 4 times daily. Side effects include palpitations, headaches, and tremors. Nursing considerations include warning patients about the risk of paradoxical bronchospasm, supervising young children using the inhaler, and advising patients not to increase dosage without consulting their physician first.
This drug card summarizes information about Albuterol (AccuNeb, Proventil, VoSpire) for pediatric patients. It provides the drug classification, recommended dosages based on weight (ranging from 0.63mg to 2.5mg), administration route of inhalation via nebulizer, and frequency of every 5 to 15 minutes as needed up to 4 times daily. Side effects include palpitations, headaches, and tremors. Nursing considerations include warning patients about the risk of paradoxical bronchospasm, supervising young children using the inhaler, and advising patients not to increase dosage without consulting their physician first.
This drug card summarizes information about Albuterol (AccuNeb, Proventil, VoSpire) for pediatric patients. It provides the drug classification, recommended dosages based on weight (ranging from 0.63mg to 2.5mg), administration route of inhalation via nebulizer, and frequency of every 5 to 15 minutes as needed up to 4 times daily. Side effects include palpitations, headaches, and tremors. Nursing considerations include warning patients about the risk of paradoxical bronchospasm, supervising young children using the inhaler, and advising patients not to increase dosage without consulting their physician first.
This drug card summarizes information about Albuterol (AccuNeb, Proventil, VoSpire) for pediatric patients. It provides the drug classification, recommended dosages based on weight (ranging from 0.63mg to 2.5mg), administration route of inhalation via nebulizer, and frequency of every 5 to 15 minutes as needed up to 4 times daily. Side effects include palpitations, headaches, and tremors. Nursing considerations include warning patients about the risk of paradoxical bronchospasm, supervising young children using the inhaler, and advising patients not to increase dosage without consulting their physician first.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 2
NURSING 260 PEDIATRIC DRUG CARD
Medication:
Dose: Weighing 15 Route: Frequency: kg or less: 0.63 mg or Inhalation by Given over 5 to 15 minutes Albuterol (AccuNeb, Proventil, 1.25 mg. Weighing nebulizer. t.i.d. or q.i.d. with VoSpire) more than 15 kg: 2.5 subsequent doses adjusted mg to response. Recommended Pediatric Dosages: Weighing 15 kg or less: 0.63 mg or 1.25 mg. (this child weighs 6.7 kg). Weighing 15 kg > ; 2.5 mg (May be given t.i.d. or q.i.d. in either instance) Minimum/dose: Maximum/dose: For a child weighing 6.7 kg, the minimum dose is 0.63 For a child weighing 6.7 kg, the maximum dose is 1.25 mg given t.i.d. or q.i.d. mg given t.i.d. or q.i.d. For a teenager weighting 45 kg, the dose is fixed at 2.5 For a teenager weighting 45 kg, the dose is fixed at 2.5 mg given t.i.d. or q.i.d. mg given t.i.d. or q.i.d. Minimum/day: 0.63 mg x t.i.d. = 1.26 mg per day 0.63 mg x q.i.d. = 1.89 mg per day 2.5 mg x t.i.d. = 5 mg per day 2.5 mg x q.i.d. = 7.5 mg per day
(infant) (infant) (teenager) (teenager)
Maximum/day: 8.38 mg x t.i.d. = 16.76 mg per day (infant) 8.38 mg x q.i.d. = 25.14 mg per day (infant) 2.5 mg x t.i.d. = 5 mg per day (teenager) 2.5 mg x q.i.d. = 7.5 mg per day (teenager)
Class: Include classification of drug, trade name and generic, dosage, route and frequency
Albuterol sulfate AccuNeb Therapeutic: Bronchodilator. Pharmacologic: Adrenergic (dosage, route, frequency = see above). Action: Albuterol acts by selectively binding to beta2-adrenergic receptors in bronchial smooth muscle to cause bronchodilation. Purpose: Albuterol is a short-acting bronchodilator that is used to relieve and prevent the bronchospasm that is a characteristic pathophysiological feature of asthma and bronchiolitis. Its rapid onset and excellent safety profile have made inhaled albuterol a drug of choice for the termination of bronchospasms. It also facilitates mucus drainage and can inhibit the release of inflammatory chemicals from mast cells. Side effects: Some patients experience palpitations, headaches, throat irritations, tremor, nervousness, restlessness, and tachycardia. Less common adverse reactions include dry mouth and insomnia. Uncommon adverse effects include chest pain, paradoxical bronchospasm, and allergic reactions. Nursing considerations/teaching: * Warn patient about risk of paradoxical bronchospasm and to stop drug immediately if it occurs. * Supervise younger children over the age of 2 to ensure appropriate use of the inhaler * Patient should know to avoid the concurrent use of monoamine oxidase inhibitors within 14 days of beginning therapy since it could lead to possible HTN crisis. * Clean mouthpiece at least weekly by removing the drug canister and running warm water through the top and bottom, shaking out excess water, and allowing to air dry. This will help to ensure there is no medication buildup with resulting improper drug delivery. * Advise patient not to use more frequently than prescribed and not to increase dose or frequency without consulting physician. * Drug is contraindicated in patients hypersensitive to drug or its ingredients. * Use cautiously in patients with CV disorders, hyperthyroidism, DM, and in those who are unusually responsive to adrenergics. OVERDUE S&S: Exaggeration of adverse reactions, seizures, angina, hypotension, hypokalemia, cardiac arrest.
